Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Mouse Model
100%
Recombinant
100%
DNA Sequencing
100%
Long-term Maintenance
100%
Novel Recombinant
100%
Antigenemia
100%
Circulating Tumor DNA (ctDNA)
100%
Covalently Closed Circular DNA
100%
Adenovirus
37%
Hepatitis B Virus
25%
DNA Persistence
25%
Virus
12%
Quantitative PCR
12%
Recombination
12%
Mode of Action
12%
Intervention Strategies
12%
Capsid
12%
Translational Research
12%
Hepatic Inflammation
12%
Hepatitis B Surface Antigen (HBsAg)
12%
Hepatitis B Virus Infection
12%
Fibrosis
12%
Viral Persistence
12%
Flow Cytometric Analysis
12%
Cre-loxP
12%
Post-transcriptional
12%
Delivery Strategy
12%
CD8+ T Cell Response
12%
Immune-tolerant
12%
Entecavir
12%
Small Animal Model
12%
Single-cell RNA Sequencing (scRNA-seq)
12%
Allosteric Modulator
12%
Transcription Inhibitors
12%
Adeno-associated Viral Vector
12%
Vector Delivery
12%
Southern Blotting
12%
Anti-hepatitis B Virus
12%
Viral Markers
12%
Experimental Duration
12%
Hepatitis B Core-related Antigen
12%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Recombinant
100%
Circular DNA
100%
Hepatitis B Virus
30%
Adeno Associated Virus
30%
Inflammation
10%
Flow Cytometry
10%
Fibrosis
10%
Hepatitis B
10%
Adeno Associated Virus Vector
10%
Entecavir
10%
Hepatitis B Antigen
10%
Allosteric Modulator
10%
CD8 Antigen
10%
RNA-Sequencing
10%
Immunology and Microbiology
Mouse Model
100%
Hepatitis B Virus
60%
Adeno Associated Virus
60%
Virus
20%
Cytotoxic T-Cell
20%
Hepatitis B
20%
Real-Time Polymerase Chain Reaction
20%
Capsid
20%
HBsAg
20%
Hepatitis B Antigen
20%
RNA Sequence
20%
Adeno Associated Virus Vector
20%
Southern Blotting
20%
HBcAg
20%